Clinical trial
Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.
NCT04882618
Study timeline
Study start (actual)2019-11-08Date precision: day
Registry last updated2021-05-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Lymph Node Metastasesunresolved
Interventions
Indocyanine greenDRUG · verified · RxNorm: indocyanine green
Sponsors & collaborators
TC Erciyes Universitylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04882618 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.